Develop Brain Cancer Therapy

Xintela AB

25/10/2018 07:41

Oct 25 (Reuters) - Xintela AB  XINT.ST :
    * XINTELA AND CATALENT TO CO-DEVELOP BRAIN CANCER THERAPY
    * PARTIES TO JOINTLY DEVELOP ADC THERAPEUTIC PRODUCT WITH FIRST FOCUS ON GLIOBLASTOMA
    * PARTIES TO CO-FINANCE DEVELOPMENT AND JOINTLY WORK TO LICENSE PROJECT TO THIRD PARTY

Source text for Eikon:  ID:nBQN2wYbfP 
Further company coverage:  XINT.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))